Author(s): de Oliveira Crispim JC, Silva TG, Souto FJ, Souza FF, Bassi CL,
Abstract Share this page
Abstract Chronic hepatitis C virus (HCV) infection is a worldwide health problem that may evolve to cirrhosis and hepatocellular carcinoma. Incompletely understood immune system mechanisms have been associated with impaired viral clearance. The nonclassical class I human leukocyte antigen G (HLA-G) molecule may downregulate immune system cell functions exhibiting well-recognized tolerogenic properties. HCV genotype was analyzed in chronic HCV-infected patients. Because HLA-G expression may be induced by certain viruses, we evaluated the presence of HLA-G in the liver microenvironment obtained from 89 biopsies of patients harboring chronic HCV infection and stratified according to clinical and histopathological features. Overall, data indicated that HCV genotype 1 was predominant, especially subgenotype 1a, with a prevalence of 87\%. HLA-G expression was observed in 45 (51\%) liver specimens, and it was more frequent in milder stages of chronic hepatitis (67.4\%) than in moderate (27.8\%; p = 0.009) and severe (36.0\%; p = 0.021) stages of the disease. Altogether, these results suggest that the expression of HLA-G in the context of HCV is a complex process modulated by many factors, which may contribute to an immunologic environment favoring viral persistence. However, because the milder forms predominantly expressed HLA-G, a protective role of this molecule may not be excluded. Copyright Â© 2012 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
This article was published in Hum Immunol
and referenced in Journal of Clinical & Cellular Immunology